ABSTRACT
Lactic acid bacteria are known as agents that help prevent digestive disorders such as acute diarrheal disease, which is one of the main causes of mortality and morbidity in children worldwide, caused mainly by bacteria, viruses and parasites.
objective To evaluate in vitro the inhibitory effect of lactic acid bacteria with probiotic potential isolated from coastal cheese and raw milk on pathogenic bacteria causing acute diarrheal disease. Materials and methods. A cross-sectional descriptive study was carried out. From 78 samples, 93 isolates were made in Man Rogosa Sharpe agar at 37oC for 48 hours in an anaerobic atmosphere. The probiotic capacity was evaluated by tolerance tests to: pH (2, 3, 4, 5 and 6), bile salts (0.05, 0.1, 0.15, 0.3%), and NaCl (2, 4, 7, 10%); growth was determined at temperatures of (30, 37 and 40°C) and the inhibitory effect in vitro against Salmonella enterica subsp enterica ATCC 14028, Staphylococcus aureus ATCC 29213, Escherichia coli ATCC 25922, Yersinia enterocolitica ATCC 23715, Shigella flexneri ATCC 12022 and Listeria monocytogenes ATCC 19115. Strains that met the requirements to be considered possible probiotics were identified biochemically by the standardized API 50 CHL system. Results. Of all the strains evaluated, four showed probiotic potential. With respect to its inhibitory effect, the tests showed inhibition against one or several microorganisms except L. monocytogenes. These strains were identified as Lactobacillus plantarum and Lactobacillus delbrueckii spp delbrueckii. Conclusions. Raw milk and coastal cheese are an important source of isolation for Lactobacillus spp. with probiotic potential, determining a positive effect against inhibition of gastrointestinal pathogens, being able to contribute to the development of strategies for the prevention of acute diarrheal diseases.
SUMMARY Lactic acid bacteria are known as agents that help prevent digestive disorders such as acute diarrheal disease, which is one of the main causes of mortality and morbidity in children worldwide, caused mainly by bacteria, viruses and parasites. Objective. To evaluate in vitro the inhibitory effect of lactic acid bacteria with probiotic potential isolated from coastal cheese and raw milk on pathogenic bacteria causing acute diarrheal disease. Materials and methods. A descriptive cross-sectional study was conducted. From 78 samples, 93 strains were isolated on Man Rogosa Sharpe agar at 37oC for 48 hours in an anaerobic atmosphere. The probiotic capacity was evaluated by tolerance tests to: pH (2, 3, 4, 5 and 6), bile salts (0.05, 0.1, 0.15, 0.3%), and NaCl (2, 4, 7, 10%); its growth was determined at temperatures of (30, 37 and 40 °C) and the in vitro inhibitory effect against Salmonella entericasubsp enterica ATCC 14028, Staphylococcus aureus ATCC 29213, Escherichia coli ATCC 25922, Yersinia enterocolitica ATCC 23715, Shigella flexneri ATCC 12022 and Listeria monocytogenes ATCC 19115.
Strains that met the requirements to be considered possible probiotics were biochemically identified.using the standardized API system®50 CHL. Results. Of all the strains evaluated, four showed probiotic potential. Regarding their inhibitory effect, the tests showed inhibition against one or more microorganisms except L. monocytogenes. These strains were identified as Lactobacillus plantarum and Lactobacillus delbrueckii spp. delbrueckii. Conclusions. Raw milk and coastal cheese are an important source of isolation of Lactobacillus spp. with probiotic potential, determining a positive effect against the inhibition of gastrointestinal pathogens, and may contribute to the development of strategies for the prevention of acute diarrheal diseases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵‡ UdeA, PECET and BIOTECH MOLECULAR research group. Molecular, genetic and computational biology line. Antioquia, Medellín, Colombia. Program for the Study and Control of Tropical Diseases (PECET) research group. Faculty of Medicine, University of Antioquia, Medellín, Colombia.
lmchams{at}correo.unicordoba.edu.co
sofy1383{at}hotmail.com
yuris.ortega.diaz{at}gmail.com
jorkaett14{at}gmail.com
riosmarinleidy5{at}gmail.com
Data Availability
All data produced in the present study are available upon reasonable request to the authors